Prescient Therapeutics (ASX:PTX) Receives R&D Tax Rebate of A$1.03m

  • November 11, 2020 04:18 PM AEDT
  • Kunal Sawhney
    CEO Kunal Sawhney
    2781 Posts

    Kunal Sawhney is founder & CEO at Kalkine and is a richly experienced and accomplished financial professional with a wealth of knowledge in the Australian Equities Market. Kunal obtained a Master of Business Administration degree from University of T...

ASX-listed oncology company Prescient Therapeutics Limited (ASX:PTX) has received its R&D Tax Incentive rebate amounting to A$1.03 million for the financial year 2019/2020.

26th feb webinar mtf mobile

This rebate is in addition to the A$18.6 million cash reserves reported in the Quarterly Update of September 2020.

The R&D Tax Incentive is an Australian Government program. It provides companies cash refunds of up to 43.5% of eligible expenditure on R&D.

Prescient stated that rebate was accounted for in its 2020 Annual Report as a receivable and will be reflected in Appendix 4C of December 2020.

On 11 November 2020, the share price of PTX quoted at A$0.064 up by 3.225% at AEST 2:17 PM.

 

 


Disclaimer
The website https://kalkinemedia.com/au is a service of Kalkine Media Pty. Ltd. (Kalkine Media) A.C.N. 629 651 672. The principal purpose of the content on this website is to provide factual information only and does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. In providing you with the content on this website, we have not considered your objectives, financial situation or needs. You should make your own enquiries and obtain your own independent advice prior to making any financial decisions.
Some of the images that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed on this website unless stated otherwise. The images that may be used on this website are taken from various sources on the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image. The information provided on the website is in good faith, however Kalkine Media does not make any representation or warranty regarding the content, accuracy, or use of the content on the website.

 

   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK